Global Brachytherapy Market Overview
According to SPER Market Research, the Global Brachytherapy Market is estimated to reach USD 1.84 billion by 2032 with a CAGR of 7.33%.
Brachytherapy equipment is recommended over other radiation therapy equipment for cancer therapy because patients treated with this equipment have a low chance of experiencing a future relapse. Image Guided Brachytherapy (IGBT) and Pulse Dose Rate are two other contemporary brachytherapy techniques (PDR). Brachytherapy is currently enabled by programming agreements that enable the providers of medical services to legally provide and schedule brachytherapy for patients. In the previous years, the prostate cancer market was anticipated to dominate and account for the largest income share. Brachytherapy is a viable treatment option for all individuals with confined prostate cancer development, both when used alone and in conjunction with outer bar radiation therapy. The category is being driven by the promising applications of brachytherapy in the treatment of prostate cancer. During the projection period, a significant CAGR is anticipated for the breast cancer brachytherapy application segment. One of the main factors propelling the development of this market is the growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI). Additionally, the growing incidence of breast cancer is anticipated to fuel the growth of this market.
Impact of COVID-19 on the Global Brachytherapy Market
Global healthcare systems have been impacted by the COVID-19 epidemic, and the market for brachytherapy equipment has also been significantly impacted. According to last year study titled "The Impact of COVID-19 on Brachytherapy," Advances in radiation oncology allowed six patients with unfavourable intermediate- and high-risk diseases to elect to receive EBRT followed by a brachytherapy boost, and since elective surgeries had to be postponed within the system due to the pandemic, four patients were treated with brachytherapy instead. The majority of cancer patients were safely treated with just minimal treatment delays and disruptions, despite the difficulties the healthcare system experienced throughout the epidemic. Therefore, they were considerably impacted as a result of the restrictions imposed by COVID-19. However, the need for brachytherapy equipment is anticipated to increase due to the rise in cardiac procedures.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Product, By Dosage Type, By End User, By Application.
|
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
|
| Companies Covered | Argon Medical Devices, Becton, Best Vascular, Carl Zeiss Meditec AG, CIVCO MEDICAL SOLUTIONS, Dickinson and Company, Eckert & Zieglet BEBIG A.G, Elekta AB, iCAD Inc, Isoray Inc, Panacea Medical Technology Pvt. Ltd., RadiaDyne, SUN NUCLEAR CORPORATION, Theragenics Corporation, VARIAN MEDICAL SYSTEMS, Inc.
|
Global Brachytherapy Market Segmentation:
1. By Product:
- Applicators & Afterloaders
- Electronic Brachytherapy
- Seeds
2. By Dosage Type:
- High-Dose Rate (HDR)Brachytherapy
- Low-Dose Rate (LDR)Brachytherapy
3. By Application:
- Breast Cancer
- Gynecological Cancer
- Prostate Cancer
- Others
4. By End-User:
- Hospitals
- Specialty Clinics
- Others
5. By Region:
- Asia-Pacific
- Europe
- Middle East
- Africa
- North America
- Latin America
Key Topics Covered in the Report:
Size of Global Brachytherapy Market (FY’2019-FY’2032)
Overview of Global Brachytherapy Market
Segmentation of Global Brachytherapy Market By Product (Applicators & Afterloaders, Electronic Brachytherapy, Seeds)
Segmentation of Global Brachytherapy Market By Dosage (High-Dose Rate (HDR)Brachytherapy, Low-Dose Rate (LDR)Brachytherapy)
Segmentation of Global Brachytherapy Market By End User (Hospitals, Specialty Clinics, Others)
Segmentation of Global Brachytherapy Market By Application (Breast Cancer, Gynecological Cancer, Prostate Cancer, Others)
Statistical Snap of Global Brachytherapy Market
Growth Analysis of Global Brachytherapy Market
Problems and Challenges in Global Brachytherapy Market
Competitive Landscape in the Global Brachytherapy Market
Impact of COVID-19 and Demonetization on Global Brachytherapy Market
Details on Recent Investment in Global Brachytherapy Market
Competitive Analysis of Global Brachytherapy Market
Major Players in the Global Brachytherapy Market
SWOT Analysis of Global Brachytherapy Market
Global Brachytherapy Market Future Outlook and Projections (FY’2019-FY’2032)
Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Brachytherapy Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Brachytherapy Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Brachytherapy Market
7. Global Brachytherapy Market, By Product, 2019-2032 (USD Million)
7.1 Applicators & Afterloaders
7.2 Electronic Brachytherapy
7.3 Seeds
8. Global Brachytherapy Market, By Dosage Type, 2019-2032 (USD Million)
8.1 High-Dose Rate (HDR)Brachytherapy
8.2 Low-Dose Rate (LDR)Brachytherapy
9. Global Brachytherapy Market, By Application, 2019-2032 (USD Million)
9.1 Breast Cancer
9.2 Gynecological Cancer
9.3 Prostate Cancer
9.4 Others
10. Global Brachytherapy Market, By End-User, 2019-2032 (USD Million)
10.1 Hospitals
10.2 Specialty Clinics
10.3 Others
11. Global Brachytherapy Market, By Region, 2019-2032 (USD Million)
11.1 Global Brachytherapy Market Size and Market Share by Region (2019-2025)
11.2 Global Brachytherapy Market Size and Market Share by Region (2026-2032)
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Europe
11.4.1 France
11.4.2 Germany
11.4.3 Italy
11.4.4 Spain
11.4.5 United Kingdom
11.4.6 Rest of Europe
11.5 Middle East and Africa
11.5.1 Kingdom of Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 Rest of Middle East & Africa
11.6 North America
11.6.1 Canada
11.6.2 Mexico
11.6.3 United States
11.7 Latin America
11.7.1 Argentina
11.7.2 Brazil
11.7.3 Rest of Latin America
12.Company Profiles
12.1 Argon Medical Devices
12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments
12.2 Becton
12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments
12.3 Best Vascular, Inc
12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments
12.4 Carl Zeiss Meditec AG
12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments
12.5 CIVCO MEDICAL SOLUTIONS
12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments
12.6 Dickinson and Company
12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments
12.7 Eckert & Ziegler BEBIG S.A
12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments
12.8 Elekta AB.
12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments
12.9 iCAD Inc
12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments
12.10 Isoray Inc
12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments
12.11 Panacea Medical Technology Pvt. Ltd.
12.11.1 Company details
12.11.2 Financial outlook
12.11.3 Product summary
12.11.4 Recent developments
12.12 RadiaDyne
12.12.1 Company details
12.12.2 Financial outlook
12.12.3 Product summary
12.12.4 Recent developments
12.13 SUN NUCLEAR CORPORATION
12.13.1 Company details
12.13.2 Financial outlook
12.13.3 Product summary
12.13.4 Recent developments
12.14 Theragenics Corporation
12.14.1 Company details
12.14.2 Financial outlook
12.14.3 Product summary
12.14.4 Recent developments
12.15 VARIAN MEDICAL SYSTEMS, INC.
12.15.1 Company details
12.15.2 Financial outlook
12.15.3 Product summary
12.15.4 Recent developments
13.List of Abbreviations
14.Reference Links
15.Conclusion
16.Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
